Association of AKT expression with degree of pathologic response in patients with esophageal cancer undergoing neoadjuvant therapy.

被引:1
|
作者
Saeed, Nadia
Doepker, Matthew
Shridhar, Ravi
Weber, Jill
Hoffe, Sarah E.
Almhanna, Khaldoun
Meredith, Kenneth L.
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiat Oncol, Tampa, FL 33682 USA
[3] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA
关键词
D O I
10.1200/jco.2015.33.3_suppl.89
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
89
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Neutrophil to lymphocyte ratios and pathologic response to neoadjuvant therapy in esophageal cancer.
    Bronson, Nathan W.
    Luna, Renato
    Bloker, Lisa M.
    Douthit, Miriam A.
    Diggs, Brian S.
    Dolan, James P.
    Hunter, John G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [12] Recurrence patterns in esophageal cancer patients undergoing curative trimodality therapy.
    Chan, Edwin
    Vanderwater, Catherine
    Woo, Rachel
    Cho, Charles
    Wong, Jason
    Xu, Wei
    Zhang, Qihuang
    Liu, Geoffrey
    Zhang, Beibei
    Cheung, Agnes
    Lee, Alex
    Chacko, Pravin Philip
    Fadhel, Ehab
    Kassam, Zahra
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [13] Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy
    Huerter, Mary E.
    Charles, Eric J.
    Downs, Emily A.
    Hu, Yinin
    Lau, Christine L.
    Isbell, James M.
    McMurry, Timothy L.
    Kozower, Benjamin D.
    ANNALS OF THORACIC SURGERY, 2016, 102 (03): : 948 - 954
  • [14] Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer
    Haisley, Kelly R.
    Laird, Amy E.
    Nabavizadeh, Nima
    Gatter, Ken M.
    Holland, John M.
    Vaccaro, Gina M.
    Thomas, Charles R., Jr.
    Schipper, Paul H.
    Hunter, John G.
    Dolan, James P.
    JAMA SURGERY, 2016, 151 (11)
  • [15] The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
    Dreyer, Stephan B.
    Powell, Arfon G. M. T.
    McSorley, Stephen T.
    Waterston, Ashita
    Going, James J.
    Edwards, Joanne
    McMillan, Donald C.
    Horgan, Paul G.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (05) : 1295 - 1303
  • [16] The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
    Stephan B. Dreyer
    Arfon G. M. T. Powell
    Stephen T. McSorley
    Ashita Waterston
    James J. Going
    Joanne Edwards
    Donald C. McMillan
    Paul G. Horgan
    Annals of Surgical Oncology, 2017, 24 : 1295 - 1303
  • [17] Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer
    Tiesi, Gregory
    Park, Wungki
    Gunder, Meredith
    Rubio, Gustavo
    Berger, Michael
    Ardalan, Bach
    Livingstone, Alan
    Franceschi, Dido
    JOURNAL OF SURGICAL RESEARCH, 2017, 216 : 65 - 72
  • [18] Immune correlates of pathologic response in bladder cancer patients undergoing neoadjuvant chemotherapy
    Abbosh, Philip H.
    Liu, David
    Choi, Woonyoung
    El-Deiry, Wafik S.
    Rosenberg, Jonathan E.
    McConkey, David
    Plimack, Elizabeth R.
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2017, 77
  • [19] IMMUNE CORRELATES OF PATHOLOGIC RESPONSE IN BLADDER CANCER PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY
    Abbosh, Philip
    Liu, David
    Choid, Woonyoung
    El-Deiry, Wafik
    Rosenberg, Jonathan
    McConkey, David
    Plimack, Elizabeth
    Van Allen, Eliezer
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1178 - E1178
  • [20] Long-Term Survival Based on Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer
    Tiesi, Gregory
    Stuart, Heather
    Yakoub, Danny
    Avisar, Eli
    Merchant, Nipum
    Livingstone, Alan S.
    Franceschi, Dido
    GASTROENTEROLOGY, 2016, 150 (04) : S1175 - S1175